< Back to Article

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial

Fig 1

Trial participants profile.

doi: https://doi.org/10.1371/journal.pntd.0007966.g001